Silencing Trim21 in mice increased HCC oncogenesis in a non-alcoholic steatohepatitis (NASH) context, which was due to overexpression of PD-1 in lymphocytes and PD-L1 in tumors (108). The gene discussed is TRIM21; the disease is metabolic dysfunction-associated steatohepatitis.